Grand Pharmaceutical Group Ltd 00512
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Trading Information
- Previous Close Price
- HK$4.63
- Day Range
- HK$4.57–4.74
- 52-Week Range
- HK$4.52–8.97
- Bid/Ask
- HK$4.56 / HK$4.59
- Shares Outstanding
- 3.50B
- Market Cap
- HK$16.07B
- Volume/Avg
- 3M / 5M
Key Statistics
- Price/Earnings (Normalized)
- 13.57
- Price/Sales
- 1.32
- Dividend Yield (Trailing)
- 3.68%
- Dividend Yield (Forward)
- 3.68%
- Dividend Payment Schedule
- Jun
- Total Yield
- 3.68%
Company Profile
Grand Pharmaceutical Group Ltd are principally engaged in the manufacture and sales of pharmaceutical technology products, manufacture and sales of bio-technology products as well as manufacture and sales of nuclear medicine anti-tumor diagnosis and treatment and cerebro-cardiovascular precision interventional diagnosis and treatment technology products, in the People's Republic of China. The operation of the group constitutes one single reportable segment. The company has presence in The PRC, America, Europe, Asia other than the PRC and Others. The majority of revenue comes from the PRC. Its brands are breathe, biology, Cardiovascular emergency care, Cardiovascular intervention, ENT, tumor.
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- Stock Style Box
- Mid Value
- Total Number of Employees
- 12,614
- Website
- https://www.grandpharm.com
Valuation
|
Metric
|
00512
|
|---|---|
Price/Earnings (Normalized) | 13.57 |
Price/Book Value | 0.96 |
Price/Sales | 1.32 |
Price/Cash Flow | 10.74 |
Price/Earnings
00512
Financial Strength
|
Metric
|
00512
|
|---|---|
Quick Ratio | 0.98 |
Current Ratio | 1.34 |
Interest Coverage | 9.66 |
Quick Ratio
00512
Profitability
|
Metric
|
00512
|
|---|---|
Return on Assets (Normalized) | 5.01% |
Return on Equity (Normalized) | 7.96% |
Return on Invested Capital (Normalized) | 6.73% |
Return on Assets
00512
Drug Manufacturers - Specialty & Generic Industry Comparables
|
1-Day Chart
|
Name
|
Price
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|---|
| Merck KGaA ADR
MKKGY
| LOCK|%?#fswr | LOCK|>Bpp | $70B | |||
| Teva Pharmaceutical Industries Ltd
TEVA
| LOCK|j#W<c<! | LOCK|PTv&! | $48B | |||
| Haleon PLC ADR
HLN
| LOCK|wnj$>> | LOCK|QX@ | $44B | |||
| Zoetis Inc Class A
ZTS
| LOCK|#vJX>>w | LOCK|&R | $33B | |||
| Viatris Inc
VTRS
| LOCK|&@>zzd | LOCK|^t | $21B | |||
| Elanco Animal Health Inc
ELAN
| LOCK|H& | LOCK|yJ | $12B | |||
| Dr Reddy's Laboratories Ltd ADR
RDY
| LOCK|#!>gJ$x | LOCK|mSh | $11B | |||
| Hims & Hers Health Inc Ordinary Shares - Class A
HIMS
| LOCK|<pGk^> | LOCK|<F | $7B | |||
| Prestige Consumer Healthcare Inc
PBH
| LOCK|wF<JMb& | LOCK|$&y# | $2B | |||
| Perrigo Co PLC
PRGO
| LOCK|lfg&p> | LOCK|m< | $2B |
United States